Evidence map›Paper›PMID 36645078›Full record

ArticleJournal of the American Heart Association2023

Heart-Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke: Characteristics of Guideline-Recommended Coronary Revascularization and Antithrombotic Therapy and Cardiovascular and Bleeding Outcomes.

Toshiaki Suzuki, Yu Kataoka, Masayuki Shiozawa, Kensuke Morris, Eri Kiyoshige, Kunihiro Nishimura, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama and 11 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Toshiaki SuzukiDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0001-9386-2432
Yu KataokaDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0001-6307-5593
Masayuki ShiozawaDepartment of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-8071-7284
Kensuke MorrisDepartment of Preventive Cardiology National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0003-0535-5532
Eri KiyoshigeDepartment of Preventive Cardiology National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-0558-9323
Kunihiro NishimuraDepartment of Preventive Cardiology National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-0639-0949
Kota MuraiDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-5162-4783
Kenichiro SawadaDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.
Takamasa IwaiDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.
Hideo MatamaDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.
Satoshi HondaDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-1393-4270
Masashi FujinoDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-2706-4317
Shuichi YonedaDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.
Kensuke TakagiDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.
Fumiyuki OtsukaDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0003-4162-2036
Yasuhide AsaumiDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-9009-7234
Masatoshi KogaDepartment of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-6758-4026
Masafumi IharaDepartment of Neurology National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-7102-4048
Kazunori ToyodaDepartment of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0002-8346-9845
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Teruo NoguchiDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.ORCID 0000-0001-5372-4932
National Cerebral and Cardiovascular Center · JPHonda (Japan) · JPKumamoto University · JPOtsuka (Japan) · JPSuzuki (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Acute myocardial infarction (AMI) infrequently occurs after acute stroke. The Heart-brain team approach has a potential to appropriately manage this poststroke cardiovascular complication. However, clinical outcomes of AMI complicating acute stroke (AMI-CAS) with the heart-brain team approach have not been characterized. The current study investigated cardiovascular outcomes in patients with AMI-CAS managed by a heart-brain team. Methods and Results We retrospectively analyzed 2390 patients with AMI at our institute (January 1, 2007-September 30, 2020). AMI-CAS was defined as the occurrence of AMI within 14 days after acute stroke. Major adverse cerebral/cardiovascular events (cardiac-cause death, nonfatal myocardial infarction, and nonfatal stroke) and major bleeding events were compared in subjects with  AMI-CAS and those without acute stroke. AMI-CAS was identified in 1.6% of the subjects. Most AMI-CASs (37/39=94.9%) presented ischemic stroke. Median duration of AMI from the onset of acute stroke was 2 days. Patients with AMI-CAS less frequently received primary percutaneous coronary intervention (43.6% versus 84.7%;

Indexed as

Fibrinolytic AgentsMyocardial InfarctionPercutaneous Coronary InterventionStrokeHemorrhageHumansRetrospective StudiesRisk FactorsTreatment OutcomeFibrinolytic Agentsacute myocardial infarctionacute strokeantithrombotic therapybleedingheart‐brain team approach

Identifiers

PMID36645078
PMCPMC9939076
OpenAlexW4316468766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.